Stephen L. Huhn insider trades
Open-market stock purchases and sales by Stephen L. Huhn, CMO & Sr VP, Clinical Dev. at Contineum Therapeutics, Inc, from SEC Form 4 filings since May 24, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- CTNM Contineum Therapeutics, Inc: other filings, last Jan 31, 2025